TEVA 7617 (Hydrochlorothiazide and Olmesartan Medoxomil 25 mg / 40 mg)
Pill with imprint TEVA 7617 is Yellow, Elliptical / Oval and has been identified as Hydrochlorothiazide and Olmesartan Medoxomil 25 mg / 40 mg. It is supplied by Teva Pharmaceuticals USA, Inc..
Hydrochlorothiazide/olmesartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/olmesartan 25 mg / 40 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEVA 7617
Hydrochlorothiazide and Olmesartan Medoxomil
- Imprint:
- TEVA 7617
- Strength:
- 25 mg / 40 mg
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Angiotensin II inhibitors with thiazides
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Teva Pharmaceuticals USA, Inc.
- National Drug Code (NDC):
- 00093-7617
More about hydrochlorothiazide/olmesartan
- Hydrochlorothiazide/olmesartan Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 29 Reviews
- Drug class: angiotensin II inhibitors with thiazides
- FDA Alerts (4)
Consumer resources
- Hydrochlorothiazide and olmesartan
- Olmesartan and Hydrochlorothiazide
- Olmesartan and hydrochlorothiazide (Advanced Reading)
Other brands: Benicar HCT
Professional resources
- Olmesartan Medoxomil and Hydrochlorothiazide (FDA)
- Olmesartan and Hydrochlorothiazide (Wolters Kluwer)
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
